Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Conformis stock price, quote, forecast and news

CFMS
US20717E1010
A14T0Y

Price

2.26
Today +/-
+0
Today %
+0 %
P

Conformis stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Conformis stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Conformis stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Conformis stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Conformis's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Conformis Stock Price History

DateConformis Price
9/14/20232.26 undefined
9/13/20232.26 undefined

Conformis Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Conformis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Conformis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Conformis’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Conformis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Conformis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Conformis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Conformis’s growth potential.

Conformis Revenue, EBIT and net profit per share

DateConformis RevenueConformis EBITConformis Net Income
2025e60.69 M undefined15.21 M undefined62.67 M undefined
2024e60.12 M undefined-30.54 M undefined-887.25 M undefined
2023e54.35 M undefined-35.89 M undefined-997.99 M undefined
202262.05 M undefined-46.28 M undefined-50.47 M undefined
202199.86 M undefined-3.01 M undefined-2.41 M undefined
202068.76 M undefined-25.11 M undefined-24.29 M undefined
201977.43 M undefined-25.03 M undefined-28.48 M undefined
201889.79 M undefined-29.56 M undefined-43.37 M undefined
201778.12 M undefined-55.05 M undefined-53.58 M undefined
201679.9 M undefined-56.14 M undefined-57.59 M undefined
201566.89 M undefined-55.96 M undefined-57.25 M undefined
201448.19 M undefined-45.43 M undefined-45.72 M undefined
201334.6 M undefined-47.31 M undefined-47.89 M undefined
201224.64 M undefined-44.2 M undefined-47.5 M undefined

Conformis Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201220132014201520162017201820192020202120222023e2024e2025e
2434486679788977689962546060
-41.6741.1837.5019.70-1.2714.10-13.48-11.6945.59-37.37-12.9011.11-
8.3320.5931.2531.8232.9135.9053.9346.7548.5365.6637.10---
27152126284836336523000
-44-47-45-55-56-55-29-25-25-3-46-35-3015
-183.33-138.24-93.75-83.33-70.89-70.51-32.58-32.47-36.76-3.03-74.19-64.81-50.0025.00
-47-47-45-57-57-53-43-28-24-2-50-997-88762
---4.2626.67--7.02-18.87-34.88-14.29-91.672,400.001,894.00-11.03-106.99
39.0939.0939.0921.9941.5243.3458.8964.1271.76.677.22000
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Conformis Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Conformis is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2013201420152016201720182019202020212022
                   
54.237.9117.265.545.223.626.428.7100.5648.67
6.29.114.914.713.213.211.18.59.089.77
000000.20.11.30.280.13
6.67.711.511.79.29.512.112.615.218.91
0.71.22.542.21.42.82.31.761.79
67.755.9146.195.969.847.952.553.4126.8879.27
88.71115.116.514.419.217.517.814.23
0000000000
0000000000
1.51.210.70.20.10000
0.80.80.80.86.700000
64.70.60.40.50.50.70.70.650.55
16.315.413.41723.91519.918.218.4614.78
8471.3159.5112.993.762.972.471.6145.3494.05
                   
0000000020.08
291.2318.4467.1476.5486.6513.3521.4543.8632.51634.65
-222.4-268.1-325.3-382.9-436.8-475.7-504.1-528.4-530.85-581.32
100-500-500500-3,200-1,500-900-4,000-1,112855.93
0000000000
68.949.8141.394.146.636.116.411.4100.5554.18
3.13.64.75.54.93.46.94.96.564.16
7.96.77.68.47.67.88.68.811.419.7
0.30.30.50.40.40.12.317.200.22
0000000000
2.20.30.30000000
13.510.913.114.312.911.317.830.917.9614.07
110.30.2029.714.819.62520.3620.56
0000000000
0.50.34.84.54.70.618.64.26.475.23
1.510.654.534.415.438.229.226.8325.8
1521.518.118.847.326.75660.144.7939.87
83.971.3159.4112.993.962.872.471.5145.3494.05
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Conformis provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Conformis's financial health and stability.

Assets

Conformis's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Conformis must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Conformis after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Conformis's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2013201420152016201720182019202020212022
-47-45-57-57-53-43-28-24-2-50
1223344444
0000000000
-3-2-4040150-15-9
22457146256
0010122111
0000000000
-46-43-54-49-37-25-2-18-8-50
-4-2-4-7-5-4-2-3-2-1
-8-10-35-10154-3-2-1
-413-28-4197000
0000000000
-47-10030-155400
74211454322519840
69291343327823820
-------1.00--1.00-
0000000000
14-1679-79-18-110271-51
-50.94-46.15-59.09-56.29-43.09-29.24-5.77-21.56-10.7-52.07
0000000000

Conformis stock margins

The Conformis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Conformis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Conformis.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Conformis's sales revenue. A higher gross margin percentage indicates that the Conformis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Conformis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Conformis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Conformis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Conformis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Conformis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Conformis Margin History

Conformis Gross marginConformis Profit marginConformis EBIT marginConformis Profit margin
2025e37.41 %25.07 %103.26 %
2024e37.41 %-50.8 %-1,475.81 %
2023e37.41 %-66.04 %-1,836.1 %
202237.41 %-74.58 %-81.34 %
202165.77 %-3.01 %-2.42 %
202049.04 %-36.52 %-35.33 %
201947.45 %-32.33 %-36.78 %
201854 %-32.92 %-48.3 %
201736.88 %-70.47 %-68.59 %
201633.43 %-70.26 %-72.08 %
201532.58 %-83.66 %-85.59 %
201432.81 %-94.27 %-94.87 %
201321.13 %-136.73 %-138.41 %
201211.44 %-179.38 %-192.78 %

Conformis Stock Sales Revenue, EBIT, Earnings per Share

The Conformis earnings per share therefore indicates how much revenue Conformis has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Conformis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Conformis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Conformis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Conformis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Conformis Revenue, EBIT and net profit per share

DateConformis Sales per ShareConformis EBIT per shareConformis Earnings per Share
2025e0.32 undefined0 undefined0.33 undefined
2024e0.32 undefined0 undefined-4.72 undefined
2023e0.29 undefined0 undefined-5.31 undefined
20228.59 undefined-6.41 undefined-6.99 undefined
202114.97 undefined-0.45 undefined-0.36 undefined
20200.96 undefined-0.35 undefined-0.34 undefined
20191.21 undefined-0.39 undefined-0.44 undefined
20181.52 undefined-0.5 undefined-0.74 undefined
20171.8 undefined-1.27 undefined-1.24 undefined
20161.92 undefined-1.35 undefined-1.39 undefined
20153.04 undefined-2.54 undefined-2.6 undefined
20141.23 undefined-1.16 undefined-1.17 undefined
20130.89 undefined-1.21 undefined-1.23 undefined
20120.63 undefined-1.13 undefined-1.22 undefined

Conformis business model

Conformis Inc is a medical technology company that specializes in the development, manufacturing, and marketing of customized implantable joint prostheses. The company is based in the United States and has its headquarters in Billerica, Massachusetts. History: Conformis Inc was founded in 2004 by Dr. Philipp Lang, an orthopedic surgeon and pioneer in the development of customized implants. The company's goal was to develop an innovative technology that could be used to manufacture individual prostheses for patients. Initially, Conformis focused on the development of custom prostheses for the knee joint. Over the years, the company has expanded its offerings to include other joints such as the hip. Business model: Conformis' business model is based on providing customized, implantable prostheses. Unlike traditional prostheses that are available in standard sizes, Conformis prostheses are individually manufactured for each patient. The company uses advanced 3D printing technology to produce a prosthesis that matches the specific anatomical features of the patient. Conformis prostheses offer numerous advantages over conventional prostheses. By customizing the prosthesis, a better fit and higher stability can be achieved. This can lead to better function and increased lifespan of the prosthesis. Additionally, Conformis prostheses can be implanted faster and more easily than traditional prostheses. Divisions: Conformis offers a variety of products for different joints. Knee prostheses: Conformis offers a wide range of custom knee prostheses. The offerings include partial replacement prostheses that only replace a part of the knee, as well as complete knee prostheses. All prostheses are individually manufactured for each patient to ensure optimal fit and function. Hip prostheses: Conformis also offers custom prostheses for the hip. These prostheses are designed to provide high stability and better fit. The hip prostheses are also individually made for each patient. Shoulder prostheses: Conformis offers custom prostheses for the shoulder, which are also tailored to the patient's anatomy. These prostheses can be used for rotator cuff defects as well as other shoulder problems. Products: The core product of Conformis is custom joint prostheses. The company's prostheses are individually manufactured for each patient to ensure optimal fit and function. Advanced technologies such as 3D printing and digital imaging are used in the production process. Conformis also offers implants for specialized procedures such as medial knee replacement. In addition to the prostheses, Conformis also offers implants such as screws, pins, and plates that can be used to fix bones during surgery. Conclusion: Conformis is a leading company in the medical technology field and offers specialized products that cater to the needs of patients. The company specializes in customized implantable joint prostheses and offers a wide range of products that are tailored to the needs of patients. Conformis has earned an excellent reputation in the industry and continues to strive to develop innovative products that improve the lives of patients. Conformis is one of the most popular companies on Eulerpool.com.

Conformis SWOT Analysis

Strengths

Conformis Inc offers a unique product line consisting of customized orthopedic implants tailored to individual patients. This differentiation provides a competitive advantage in the market.

The company possesses a robust intellectual property portfolio encompassing various aspects of its customized implant technology. This helps protect Conformis Inc's market position and prevents competitors from easily replicating its offerings.

Conformis Inc has established strategic partnerships with leading healthcare providers, enabling access to a wide network of potential clients. This strengthens the company's market presence and facilitates increased adoption of its products.

The customized nature of Conformis Inc's products often requires additional manufacturing steps, resulting in higher production costs compared to standardized implants. This may limit the company's price competitiveness.

Conformis Inc's products, while beneficial, have yet to achieve widespread adoption in the market. Limited market penetration poses challenges in terms of revenue growth and market expansion.

The company relies on sourcing certain components of its products from third-party suppliers. Any disruption in the supply chain can potentially impact the company's ability to meet customer demands and fulfill orders.

The increasing aging population globally presents a significant opportunity for Conformis Inc. As orthopedic conditions become more prevalent, there will be a higher demand for customized implants to optimize patient outcomes.

Rapid advancements in medical technology offer opportunities for Conformis Inc to further improve its product offerings. Innovations such as 3D printing and artificial intelligence can enhance the customization and efficiency of the company's implant solutions.

Conformis Inc has the potential to expand its market reach by targeting new geographic regions and actively pursuing partnerships with additional healthcare providers. This can help the company tap into underserved markets and increase its customer base.

The orthopedic implant industry is highly competitive, with numerous established players and emerging startups. Conformis Inc faces the threat of competitive pricing, technological advancements from competitors, and potential imitation of its customized implant concept.

Compliance with strict regulatory requirements is vital for Conformis Inc's operations. Changes in regulations or delays in obtaining necessary approvals could hinder the company's ability to introduce new products or expand into certain markets.

Economic fluctuations and uncertainties can impact the demand for orthopedic implants, as consumers may postpone or reduce non-essential healthcare expenses during challenging economic times. Conformis Inc needs to be prepared for potential shifts in market demand.

Weaknesses

The customized nature of Conformis Inc's products often requires additional manufacturing steps, resulting in higher production costs compared to standardized implants. This may limit the company's price competitiveness.

Conformis Inc's products, while beneficial, have yet to achieve widespread adoption in the market. Limited market penetration poses challenges in terms of revenue growth and market expansion.

The company relies on sourcing certain components of its products from third-party suppliers. Any disruption in the supply chain can potentially impact the company's ability to meet customer demands and fulfill orders.

The increasing aging population globally presents a significant opportunity for Conformis Inc. As orthopedic conditions become more prevalent, there will be a higher demand for customized implants to optimize patient outcomes.

Rapid advancements in medical technology offer opportunities for Conformis Inc to further improve its product offerings. Innovations such as 3D printing and artificial intelligence can enhance the customization and efficiency of the company's implant solutions.

Conformis Inc has the potential to expand its market reach by targeting new geographic regions and actively pursuing partnerships with additional healthcare providers. This can help the company tap into underserved markets and increase its customer base.

The orthopedic implant industry is highly competitive, with numerous established players and emerging startups. Conformis Inc faces the threat of competitive pricing, technological advancements from competitors, and potential imitation of its customized implant concept.

Compliance with strict regulatory requirements is vital for Conformis Inc's operations. Changes in regulations or delays in obtaining necessary approvals could hinder the company's ability to introduce new products or expand into certain markets.

Economic fluctuations and uncertainties can impact the demand for orthopedic implants, as consumers may postpone or reduce non-essential healthcare expenses during challenging economic times. Conformis Inc needs to be prepared for potential shifts in market demand.

Opportunities

The increasing aging population globally presents a significant opportunity for Conformis Inc. As orthopedic conditions become more prevalent, there will be a higher demand for customized implants to optimize patient outcomes.

Rapid advancements in medical technology offer opportunities for Conformis Inc to further improve its product offerings. Innovations such as 3D printing and artificial intelligence can enhance the customization and efficiency of the company's implant solutions.

Conformis Inc has the potential to expand its market reach by targeting new geographic regions and actively pursuing partnerships with additional healthcare providers. This can help the company tap into underserved markets and increase its customer base.

The orthopedic implant industry is highly competitive, with numerous established players and emerging startups. Conformis Inc faces the threat of competitive pricing, technological advancements from competitors, and potential imitation of its customized implant concept.

Compliance with strict regulatory requirements is vital for Conformis Inc's operations. Changes in regulations or delays in obtaining necessary approvals could hinder the company's ability to introduce new products or expand into certain markets.

Economic fluctuations and uncertainties can impact the demand for orthopedic implants, as consumers may postpone or reduce non-essential healthcare expenses during challenging economic times. Conformis Inc needs to be prepared for potential shifts in market demand.

Threats

The orthopedic implant industry is highly competitive, with numerous established players and emerging startups. Conformis Inc faces the threat of competitive pricing, technological advancements from competitors, and potential imitation of its customized implant concept.

Compliance with strict regulatory requirements is vital for Conformis Inc's operations. Changes in regulations or delays in obtaining necessary approvals could hinder the company's ability to introduce new products or expand into certain markets.

Economic fluctuations and uncertainties can impact the demand for orthopedic implants, as consumers may postpone or reduce non-essential healthcare expenses during challenging economic times. Conformis Inc needs to be prepared for potential shifts in market demand.

Conformis Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Conformis Revenue by Segment

Segmente20222021202020192018
Product57.83 M USD58.32 M USD58.54 M USD1.9 M USD-
Royalty and licensing4.23 M USD41.54 M USD10.22 M USD--
Royalty---780,000 USD-
Royalty----11.52 M USD
Product----1.56 M USD

Conformis Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Conformis historical P/E ratio, EBIT, and P/S ratio.

Conformis shares outstanding

The number of shares was Conformis in 2023 — This indicates how many shares 7.219 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Conformis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Conformis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Conformis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Conformis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Conformis Stock splits

In Conformis's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Conformis.

Conformis latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2023-1.31 -1.78  (-35.81 %)2023 Q2
3/31/2023-1.42 -1.32  (6.87 %)2023 Q1
12/31/2022-1.83 -0.51  (72.14 %)2022 Q4
9/30/2022-1.87 -2  (-6.96 %)2022 Q3
6/30/2022-1.96 -2.25  (-15.08 %)2022 Q2
3/31/2022-1.87 -2.25  (-20.33 %)2022 Q1
12/31/2021-1.87 -2.25  (-20.33 %)2021 Q4
9/30/2021-1.66 -1.75  (-5.58 %)2021 Q3
6/30/20211.08 5.25  (384.41 %)2021 Q2
3/31/2021-1.92 -2.25  (-17.25 %)2021 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Conformis stock

Eulerpool World ESG Rating (EESG©)

43/ 100

🌱 Environment

50

👫 Social

21

🏛️ Governance

58

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Conformis list of shareholders

%
Name
Stocks
Change
Date
0.39798 % Stonepine Capital Management, LLC748,19456,02012/31/2022
0.31293 % Wasatch Global Investors Inc588,299-237,41412/31/2022
0.25532 % Armistice Capital LLC480,000012/31/2022
0.15727 % The Vanguard Group, Inc.295,67015412/31/2022
0.10971 % Velan Capital Investment Management LP206,256012/31/2022
0.08671 % Renaissance Technologies LLC163,002-27,54612/31/2022
0.06364 % BlackRock Institutional Trust Company, N.A.119,645-11912/31/2022
0.05178 % Augusti (Mark A)97,349-1,0109/7/2022
0.04943 % UBS Financial Services, Inc.92,92030,84212/31/2022
0.04527 % Medical Strategy GmbH85,09809/30/2022
1
2
3
4
5
...
10

Conformis Executives and Management Board

Mr. Mark Augusti57
Conformis President, Chief Executive Officer, Director (since 2016)
Compensation 1.67 M
Ms. Denise Pedulla62
Conformis Chief Legal Officer, Corporate Secretary
Compensation 916,418
Mr. Kenneth Fallon83
Conformis Independent Chairman of the Board
Compensation 176,167
Mr. Gary Fischetti62
Conformis Independent Director
Compensation 142,666
Mr. Bradley Langdale58
Conformis Independent Director
Compensation 139,667
1
2

Conformis Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Zimmer Biomet Holdings Stock
Zimmer Biomet Holdings
SupplierCustomer0,750,850,440,460,820,50
MicroPort Scientific Stock
MicroPort Scientific
SupplierCustomer0,650,370,670,740,810,72
Stryker Corp Stock
Stryker Corp
SupplierCustomer0,560,790,800,690,610,42
Paragon 28 Stock
Paragon 28
SupplierCustomer0,540,740,490,18--
Synchrony Finl Stock
Synchrony Finl
SupplierCustomer0,300,720,360,640,730,54
Smith & Nephew Stock
Smith & Nephew
SupplierCustomer-0,300,60-0,44-0,100,550,14
1

Most common questions regarding Conformis

What values and corporate philosophy does Conformis represent?

Conformis Inc represents strong values and a clear corporate philosophy. As a leading medical technology company, Conformis focuses on providing customized orthopedic implants, designed to fit each patient's unique anatomy. Commitment to innovation, patient-centricity, and improving the quality of life drive Conformis' operations. By leveraging advanced imaging technology and proprietary software, the company aims to streamline the surgical process, enhance patient outcomes, and reduce healthcare costs. Conformis' unwavering dedication to personalized solutions and delivering exceptional patient experiences solidifies its position as a trusted leader in the orthopedic industry.

In which countries and regions is Conformis primarily present?

Conformis Inc is primarily present in the United States.

What significant milestones has the company Conformis achieved?

Conformis Inc, a leading medical technology company, has achieved several significant milestones. The company has successfully developed and commercialized innovative joint replacement implants and systems that are tailored to each patient's unique anatomy. Conformis Inc has received FDA clearance for its knee and hip replacement products, showcasing their commitment to safety and effectiveness. They have also gained regulatory approvals in various markets around the world, expanding their global presence. Additionally, Conformis Inc has secured partnerships and collaborations with renowned orthopedic organizations, enabling them to advance their research and development efforts. This dedication to innovation and strategic partnerships has positioned Conformis Inc as a leader in the orthopedic medical device industry.

What is the history and background of the company Conformis?

Conformis Inc, founded in 2004, is a leading medical technology company that specializes in orthopedic implant design and manufacturing. The company is headquartered in Billerica, Massachusetts. Conformis Inc focuses on providing patient-specific and highly customized joint replacement solutions, particularly knee and hip implants. By utilizing advanced 3D printing technology and imaging software, Conformis Inc is able to create implants that are tailored to each patient's unique anatomy, resulting in potentially better outcomes and improved patient satisfaction. The company has a successful track record of innovation and is committed to addressing the individual needs of patients while ensuring the highest quality of care.

Who are the main competitors of Conformis in the market?

Conformis Inc faces competition from various players in the orthopedic implant market. Some of its main competitors include Zimmer Biomet Holdings Inc, Stryker Corporation, and Smith & Nephew plc. These companies also specialize in manufacturing and marketing orthopedic implants, including knee and hip replacements. Conformis Inc distinguishes itself by offering patient-specific implants and instrumentation, providing a personalized approach to orthopedic surgery. Despite competition, Conformis Inc has carved a niche for itself with its innovative solutions tailored to individual patients, enhancing the overall quality of care in the orthopedic industry.

In which industries is Conformis primarily active?

Conformis Inc is primarily active in the medical devices industry.

What is the business model of Conformis?

The business model of Conformis Inc is focused on providing innovative and patient-specific solutions for orthopedic surgeons. The company develops and sells personalized joint replacement implants and associated surgical instruments. Through advanced imaging technology and proprietary software, Conformis Inc creates implants that are tailor-made for each patient, taking into account their unique anatomy. By offering this personalized approach, Conformis Inc aims to enhance patient outcomes, improve surgical efficiency, and reduce the need for secondary surgeries. This patient-specific solution sets Conformis Inc apart and positions the company as a leader in the field of orthopedic joint replacements.

What is the P/E ratio of Conformis 2024?

The Conformis P/E ratio is -0.02.

What is the P/S ratio of Conformis 2024?

The Conformis P/S ratio is 0.27.

What is the AlleAktien quality score of Conformis?

The AlleAktien quality score for Conformis is 3/10.

What is the revenue of Conformis 2024?

The expected Conformis revenue is 60.12 M USD.

How high is the profit of Conformis 2024?

The expected Conformis profit is -887.25 M USD.

What is the business model of Conformis

Conformis Inc. is a leading company in the field of medical technology that develops, manufactures, and sells specially customized orthopedic implants and instruments for use in knee, hip, and shoulder surgery. The company combines state-of-the-art technology with clinical insights to provide unique solutions for individual anatomical needs and surgical challenges. The business model is based on the production and sale of personalized implants and instruments, using computer-assisted imaging technologies and manufacturing processes to produce individualized implants and instruments in series. This allows for a precise fit and faster healing, leading to better outcomes for patients. The company is active in three main segments: knee, hip, and shoulder. In knee surgery, Conformis offers a portfolio of knee implants that are made according to the specific needs of the patient, including total, partial, cartilage, and ligament-replacing implants. In hip surgery, Conformis offers a customized acetabular cup that helps ensure a precise fit and more natural hip movements. The company also offers customized hip implants that meet the anatomical needs of the patient. In shoulder surgery, Conformis offers a wide range of individualized shoulder implants, including total and partial implants. The implants are particularly precise with regard to the rotator cuff, the size and shape of the joint head, as well as the acromion and glenoid. Conformis is also proud to offer instruments and accessories that allow surgeons to receive real-time interactive information about the patient's anatomy during the procedure. These include patient-specific templates and drill templates that accurately match the patient's anatomical requirements. Another important pillar of the business model is collaboration with clinicians and surgeons. Conformis works with renowned clinics and surgeons to constantly develop and improve new products. The company aims to reduce procedural errors and increase the efficiency of orthopedic surgery. Overall, the business model of Conformis Inc. is focused on providing personalized solutions in orthopedic surgery that help patients heal faster and better. The company focuses on product development, manufacturing, distribution, and collaboration with doctors and clinics to ensure that the patient's need for individualized solutions is optimally met. Conformis Inc. is an innovative company with a strong focus on improving patient care.

What is the Conformis dividend?

Conformis pays a dividend of 0 USD distributed over payouts per year.

How often does Conformis pay dividends?

The dividend cannot currently be calculated for Conformis or the company does not pay out a dividend.

What is the Conformis ISIN?

The ISIN of Conformis is US20717E1010.

What is the Conformis WKN?

The WKN of Conformis is A14T0Y.

What is the Conformis ticker?

The ticker of Conformis is CFMS.

How much dividend does Conformis pay?

Over the past 12 months, Conformis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Conformis is expected to pay a dividend of 0 USD.

What is the dividend yield of Conformis?

The current dividend yield of Conformis is .

When does Conformis pay dividends?

Conformis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Conformis?

Conformis paid dividends every year for the past 0 years.

What is the dividend of Conformis?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Conformis located?

Conformis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Conformis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Conformis from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Conformis pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Conformis in the year 2023?

In the year 2023, Conformis distributed 0 USD as dividends.

In which currency does Conformis pay out the dividend?

The dividends of Conformis are distributed in USD.

All fundamentals about Conformis

Our stock analysis for Conformis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conformis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.